Global Biotechnology Market is Expected to Reach US$414.5 bn by 2017

Global Biotechnology Market Recovering from Post Recession Crunch, Expected to Reach US$414.5 bn by 2017 The global biotechnology market is expected to progress at an impressive CAGR of 11.6% within a forecast period from 2012 to 2017. The market was already recorded at a low US$216.6 bn in 2011 and through a set of major changes and innovative applications, might manage to nearly double its value to US$414.5 bn by 2017.

This data is presented in a research report published by leading market intelligence provider, Transparency Market Research.

The report, titled “Global Biotechnology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2010 2017,” is a highly descriptive examination of what the market’s players and investors are currently doing, and will continue to do, in order to strengthen its growth rate.

In the recent few years, however, the demand for similar foods and beverages has gone up, thereby boosting the need for the global biotechnology market. Biotech is currently in high demand from the sectors of pharma and agriculture.

Browse Full Research Report on Biotechnology Market: http://www.transparencymarketresearch.com/biotechnology-market.html

Apart from this high demand, a large number of biotech-related industries have sped up their innovation processes in order to be on top of the new product lineups.

The major applications involved in the global biotechnology market are bio industrial, bio services, bio agriculture, and bio pharma. Nearly 60% of the global biotechnology market was occupied by biopharmaceuticals in 2011, owing to a substantially high amount of government funding and support.

Geographically speaking, the global biotechnology market was led by North America in 2011, when it held a share of 42%.

Major trends leading to this top share were the high focus on renewable chemicals and an overall higher demand for biotech related products.

At the same time, Asia Pacific is showing the fastest growth rate in the given forecast period, due to a significantly lower cost of conducting clinical trials in this region.

Browse Full Press Release on Biotechnology Market: Press Release

The Asia Pacific biotechnology market prospered especially from the booming growth of contract research organizations that

are directly linked to clinical trials. This segment is showing a growth rate of more than 20% in the Asia Pacific biotech market.

A few of the key players in the report are Biogen Idec, Inc., Sanofi-Aventis, Pfizer, Roche, Novartis, Merck, GSK, Amgen, Inc., and Abbott Laboratories. Each key player is described on the basis of their business profile and strategies, along with the analysis of their financial structures, a SWOT analysis, and the most recent developments they have made.

About Us Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis

capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com